Compare NUVB & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | BXMT |
|---|---|---|
| Founded | 2018 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | N/A | N/A |
| Metric | NUVB | BXMT |
|---|---|---|
| Price | $8.47 | $20.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | $10.63 | ★ $20.25 |
| AVG Volume (30 Days) | ★ 10.3M | 1.2M |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 9.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | $26,748,000.00 | ★ $393,335,000.00 |
| Revenue This Year | $609.55 | N/A |
| Revenue Next Year | $197.91 | $10.51 |
| P/E Ratio | ★ N/A | $32.92 |
| Revenue Growth | ★ 1137.19 | N/A |
| 52 Week Low | $1.54 | $16.51 |
| 52 Week High | $8.95 | $21.24 |
| Indicator | NUVB | BXMT |
|---|---|---|
| Relative Strength Index (RSI) | 68.52 | 73.68 |
| Support Level | $7.80 | $19.55 |
| Resistance Level | $8.95 | $19.95 |
| Average True Range (ATR) | 0.51 | 0.32 |
| MACD | -0.04 | 0.12 |
| Stochastic Oscillator | 74.78 | 91.53 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.